Company

Helex

Biotechnology New York, Ny, United States 22 employees

Employees: 22
Contacts: 1
Emails: 1

www.helex.bio LinkedIn Crunchbase

Helex Overview

Headquarters: New York, Ny, United States
Website: www.helex.bio
Industry: Biotechnology
Employees: 22
Founded: 2021

Keywords

gene editing renal disease nonviral delivery lipid nanoparticle epigenetics cell specific editing genetic medicines drug design genomic medicines

About Helex

Helex is taking the promise of non-viral targeted delivery and genome editing to the kidney, developing first-in-class genetic medicines for renal indications. Helex combines its proprietary kidney tropic lipid nanoparticle delivery system with the Epic-Cure(TM) 3D genome-based drug designer platform to create a robust renal franchise of precise and scalable therapeutics. Our lead asset is a mutation-agnostic, potential one-and-done therapy for Autosomal Dominant Polycystic Kidney Disease that impacts over 4 million people worldwide.

Helex Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Helex Org Chart

Sample employees and titles

Name	Title	Location	Contact
Prashanthi K	PMP® Certified - Program & Project Manager - Healthcare Strategy - Clinical Operations - Pharma - Leadership	Canada	View
Dr. Yugantak Raj Gupta	Junior Research Scientist - Ph.d. in Molecular Biology - Expertise in Gene Silencing, Ddpcr, Cell & Gene Therapy - Crispr - Cas9		View
Neha Gaur, Phd	Lead Scientist @ Helex - Cell & Gene Therapy - Crispr - Cas9	Hyderabad, Telangana, India	View
Rohini Kalvakuntla	Co-founder and Chief Business Officer at Helex	New York, United States	Email